A Word to the Wise About Intranasal Esketamine
Author:
- 1 June 2019
- journal article
- review article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 176 (6) , 422-424
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled StudyAmerican Journal of Psychiatry, 2019
- Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formationScience, 2019
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor AntagonismAmerican Journal of Psychiatry, 2018
- A Genetically Encoded Biosensor Reveals Location Bias of Opioid Drug ActionNeuron, 2018
- Ketamine for painF1000Research, 2017
- Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptorsBrain Research, 2014
- A Word to the Wise About KetamineAmerican Journal of Psychiatry, 2014
- Should protracted withdrawal from drugs be included in DSM-IV?American Journal of Psychiatry, 1993
- Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801Science, 1991